GR3031801T3 - Vitaletheine and use in cell culture and therapy. - Google Patents
Vitaletheine and use in cell culture and therapy.Info
- Publication number
- GR3031801T3 GR3031801T3 GR990402894T GR990402894T GR3031801T3 GR 3031801 T3 GR3031801 T3 GR 3031801T3 GR 990402894 T GR990402894 T GR 990402894T GR 990402894 T GR990402894 T GR 990402894T GR 3031801 T3 GR3031801 T3 GR 3031801T3
- Authority
- GR
- Greece
- Prior art keywords
- vitaletheine
- therapy
- cell culture
- cell
- derivatives
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title 1
- 238000002659 cell therapy Methods 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- -1 Vitaletheine Chemical class 0.000 abstract 1
- NXURKZIMAQBJEU-UHFFFAOYSA-N [3-[2-[2-[3-(carboxyamino)propanoylamino]ethyldisulfanyl]ethylamino]-3-oxopropyl]carbamic acid Chemical compound OC(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(O)=O NXURKZIMAQBJEU-UHFFFAOYSA-N 0.000 abstract 1
- OWIUPIRUAQMTTK-UHFFFAOYSA-N carbazic acid Chemical class NNC(O)=O OWIUPIRUAQMTTK-UHFFFAOYSA-N 0.000 abstract 1
- 230000003915 cell function Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000009826 neoplastic cell growth Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 239000003104 tissue culture media Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0025—Culture media for plant cell or plant tissue culture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54943890A | 1990-07-06 | 1990-07-06 | |
| US54910590A | 1990-07-06 | 1990-07-06 | |
| US54944090A | 1990-07-06 | 1990-07-06 | |
| PCT/US1991/004726 WO1992000955A1 (en) | 1990-07-06 | 1991-07-08 | Vitaletheine and use in cell culture and therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3031801T3 true GR3031801T3 (en) | 2000-02-29 |
Family
ID=27415550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR990402894T GR3031801T3 (en) | 1990-07-06 | 1999-11-10 | Vitaletheine and use in cell culture and therapy. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0539525B1 (en:Method) |
| JP (1) | JP3259960B2 (en:Method) |
| AT (1) | ATE186048T1 (en:Method) |
| AU (1) | AU655598B2 (en:Method) |
| DE (1) | DE69131752T2 (en:Method) |
| DK (1) | DK0539525T3 (en:Method) |
| ES (1) | ES2139580T3 (en:Method) |
| GR (1) | GR3031801T3 (en:Method) |
| WO (1) | WO1992000955A1 (en:Method) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU718140B2 (en) * | 1995-10-17 | 2000-04-06 | Dovetail Technologies, Inc. | Low molecular weight cell, bone marrow and immune stimulants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552765A (en) * | 1982-05-14 | 1985-11-12 | Santen Pharmaceutical Co., Ltd. | Aletheine derivatives |
| DK0538330T3 (da) * | 1990-07-06 | 1996-02-26 | Univ New Mexico | Beta-Alethin-anvendelse til celledyrkning og terapi |
-
1991
- 1991-07-08 WO PCT/US1991/004726 patent/WO1992000955A1/en not_active Ceased
- 1991-07-08 ES ES91915854T patent/ES2139580T3/es not_active Expired - Lifetime
- 1991-07-08 EP EP91915854A patent/EP0539525B1/en not_active Expired - Lifetime
- 1991-07-08 AT AT91915854T patent/ATE186048T1/de not_active IP Right Cessation
- 1991-07-08 AU AU85008/91A patent/AU655598B2/en not_active Ceased
- 1991-07-08 DE DE69131752T patent/DE69131752T2/de not_active Expired - Fee Related
- 1991-07-08 DK DK91915854T patent/DK0539525T3/da active
- 1991-07-08 JP JP51462891A patent/JP3259960B2/ja not_active Expired - Fee Related
-
1999
- 1999-11-10 GR GR990402894T patent/GR3031801T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU655598B2 (en) | 1995-01-05 |
| DE69131752T2 (de) | 2000-06-29 |
| EP0539525B1 (en) | 1999-10-27 |
| JPH06500106A (ja) | 1994-01-06 |
| DK0539525T3 (da) | 2000-04-10 |
| ATE186048T1 (de) | 1999-11-15 |
| AU8500891A (en) | 1992-02-04 |
| EP0539525A4 (en:Method) | 1994-01-12 |
| EP0539525A1 (en) | 1993-05-05 |
| HK1014367A1 (en) | 1999-09-24 |
| JP3259960B2 (ja) | 2002-02-25 |
| DE69131752D1 (de) | 1999-12-02 |
| ES2139580T3 (es) | 2000-02-16 |
| WO1992000955A1 (en) | 1992-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60009956D1 (de) | Wachstumsfaktoren und l-glutamin enthaltendes zellkulturmedium | |
| ATE347585T1 (de) | In-vitro wachstum von langerhans'schen inseln und ihre verwendungen | |
| BR9910251A (pt) | Estimulação hematopoiética | |
| ES8705845A1 (es) | Procedimiento de preparar derivados benzonaftalenicos de utilidad terapeutica y cosmetica | |
| EP0283713A3 (en) | Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them | |
| GB2276086A (en) | Pharmaceutical products for curing tumorous diseases and process for preparing same | |
| MX9101913A (es) | Derivados de quinazolinas para potenciar la actividad antitumoral | |
| ES8605375A1 (es) | Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias. | |
| ES2151607T3 (es) | Factor 12 de crecimiento y de diferenciacion. | |
| DE69535081D1 (de) | Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis | |
| CA2213322A1 (en) | Thiols to promote hematopoietic progenitor cell growth | |
| PT862452E (pt) | Formulacao de estabilizacao para o ngf | |
| ZA917767B (en) | A nutritional composition and a process for its production | |
| DE3850778D1 (de) | Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks. | |
| EP0380692A4 (en) | Plant tissue culture process | |
| ZA844742B (en) | Anthracycline derivatives,a microbiological process for their preparation and their use as cytostatics | |
| GR3031801T3 (en) | Vitaletheine and use in cell culture and therapy. | |
| GR3018632T3 (en) | Beta-alethine use in cell culture and therapy. | |
| IL131478A0 (en) | Methods for treatment of scar tissue | |
| ATE125571T1 (de) | Interleukin-1-inhibitor. | |
| EP0248217A3 (en) | Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor | |
| NZ335057A (en) | Pentaerythritol derivatives, their production and use and intermediates for their synthesis | |
| AU8478601A (en) | Methods for culturing human lung mast cells and uses thereof | |
| ES2057528T3 (es) | Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen. | |
| DE2966082D1 (en) | Process for growing human epidermal cells in tissue culture |